arrow
M

Mario M. Dorostkar

Karl Landsteiner University of Health Sciences
H指数:35
被引数:3,611

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Spinal Pilocytic Astrocytomas in Adults Show Epigenetic Divergence from Cerebral Counterparts: A Multicenter Analysis

成人脊髓毛细胐星形细胞瘤显示出与脑部对应肿瘤的表观遗传差异:一项多中心分析

2025-11-010
OAAI
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significance

综合分析揭示了H3 K27M-mutant弥漫性中线胶质瘤的两种分子和临床上不同的亚型,具有预后意义

2024-09-100
OAAI
Multiomic profiling of medulloblastoma reveals subtype-specific targetable alterations at the proteome and N-glycan level

髓母细胞瘤的多组分析揭示了蛋白质组和N-聚糖水平的亚型特异性靶向改变

2024-07-241
OAAI
Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation

脊髓室管膜瘤的转录组和表观遗传解剖 (sp-epn) 确定了具有和不具有NF2突变的肿瘤的临床相关亚型

2024-01-243
OAAI
Significance of molecular diagnostics for therapeutic decision-making in recurrent glioma
2023-05-129
OAAI
Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment
2023-02-037
PRE
Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease

黏液乳头状室上膜瘤的综合分析确定了复发性疾病的独特分子亚型

2022-04-0523
OA
Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition
2022-03-307
OAAI
Extent, pattern, and prognostic value of MGMT promotor methylation: does it differ between glioblastoma and IDH-wildtype/TERT-mutated astrocytoma?

MGMT启动子甲基化的程度、模式和预后价值: 在胶质母细胞瘤和IDH野生型/TERT突变星形细胞瘤之间是否存在差异?

2021-12-138
OAAI